New research presented at this year's European Congress on Obesity (ECO2023, Dublin, 17-20 May) shows that the obesity drug semaglutide is effective for weight loss in a multicenter, 1-year-long real-world study. The study ...
May 19, 2023
0
20
A new weight-loss treatment could be on the horizon with an innovative endoscopic procedure that ablates (burns) the stomach lining to reduce production of ghrelin, a hormone that triggers hunger, resulting in decreased appetite ...
May 9, 2024
0
2
Johns Hopkins-led research has revealed an extensive network of connections between the right and left sides of the brain when mice are exposed to different sounds. The researchers also found that some areas of the brain ...
Oct 13, 2023
0
115
When Mark Winternheimer's 12-year-old tabby cat was diagnosed with diabetes last year, the treatment was daunting: twice-daily injections of insulin, an implanted monitor and frequent visits to the vet.
Jan 23, 2023
0
204
For individuals with type 2 diabetes, long-term low-carbohydrate diets (LCD) are efficacious for treatment of dyslipidemia but do not affect glycemic control, according to a review published online July 24 in the Journal ...
Aug 3, 2024
0
1
New research has discovered that neotame, one of the new generation of artificial sweeteners, is capable of damaging the human intestine and causing illness.
Apr 24, 2024
0
5
The risk of type 2 diabetes (T2D) is more than halved by weekly injections of new obesity drug semaglutide, according to new research being presented at the annual meeting of the European Association for the Study of Diabetes ...
Sep 12, 2022
0
14
Two of the world's leading authorities on bariatric and metabolic surgery have issued new evidence-based clinical guidelines that among a slew of recommendations expand patient eligibility for weight-loss surgery and endorse ...
Oct 21, 2022
0
4
Excitement is building about a new generation of drugs that tout the ability to help adults with excess weight shed more pounds than older drugs on the market.
Oct 20, 2022
0
3
The national obesity campaign launched by the U.K. government to improve health and protect the NHS during the COVID-19 pandemic was "unproductive," "ineffective," "irresponsible" and could have led to "fat-shaming."
Oct 13, 2022
0
3
